WallachBeth Capital Starts DepoMed Inc (DEPO) at Buy
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Earlier, WallachBeth Capital initiated coverage on DepoMed Inc (NASDAQ: DEPO) with a Buy rating and $8 price target.
Analyst Difei Yang expects the company turn profitable in 2013 and with shares trading at just ~2.5x sales, low for the group. Management is strong and its product portfolio has good patent protection and they see limited competition.
Yang the most interesting near term opportunities are Gralise, Glumetza and Zipsor, which combined are expected to drive revenue growth of 93% in 2013. "If approved by the FDA, Serada could drive growth in 2014 and beyond," the analyst comments.
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $5.17 yesterday.
Analyst Difei Yang expects the company turn profitable in 2013 and with shares trading at just ~2.5x sales, low for the group. Management is strong and its product portfolio has good patent protection and they see limited competition.
Yang the most interesting near term opportunities are Gralise, Glumetza and Zipsor, which combined are expected to drive revenue growth of 93% in 2013. "If approved by the FDA, Serada could drive growth in 2014 and beyond," the analyst comments.
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $5.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
- Baird Starts Eaton Corporation (ETN) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
